Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of ANB019 in Palmoplantar Pustulosis
2017-004022-15Phase 2Completed
- Sponsor
- AnaptysBio, Inc.
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Palmoplantar Pustular Psoriasis (PPPP) and pustular psoriasis comparing ANB019 with Placebo (2 arms). Started Jan 2020; status: completed.
02
Drugs
imsidolimab
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)pustular psoriasis
Beyond the preview
Go deeper on 2017-004022-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004022-15.